Risdiplam
ATC M09AX10 · 9 markets · 21 records
Risdiplam
Forms
AU 5 records · 4 strengths
- 5 mgtabletEVRYSDIEVRYSDI risdiplam 5 mg tablet blister pack
- 0.75 mg/1 mLpowderEVRYSDI
- 0.75 mg/mLpowderEVRYSDI risdiplam 0.75 mg/mL powder for oral solution bottle
Records without a stated strength · 1 EVRYSDI
GB 3 records · 2 strengths
- 5 mgtabletEVRYSDI
Records without a stated strength · 1 Evrysdi 0.75mg/ml oral solution
US 2 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
- 5 mgtabletEVRYSDI
- 60 mgpowderEVRYSDI Powder for Oral Solution 0.75 mg/mL
ES 2 records · 2 strengths
TW 2 records · 2 strengths
- 5 mgtabletEVRYSDI服脊立膜衣錠5毫克
- 0.75 mgpowderEVRYSDI Powder for Oral Solution 0.75 mg/mL服脊立口服溶液用粉劑0.75毫克/毫升
HK 2 records · 1 strengths
Records without a stated strength · 1 EVRYSDI、EVRYSDI Powder for Oral Solution 0.75 mg/mL
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 EVRYSDI
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.